Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1995-03-16
1999-05-25
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
424 856, 512 21, 530351, A01N 2500
Patent
active
059068167
ABSTRACT:
Methods of treating autoimmune disorders, such as multiple sclerosis, are disclosed. The methods employ administration of interferon-tau (IFN.tau.) in a therapeutically-effective dose.
REFERENCES:
patent: 4997646 (1991-03-01), Hansen et al.
patent: 5109382 (1992-04-01), Cummins, Jr.
patent: 5372808 (1994-12-01), Blatt et al.
Bazer, Medline AB #92075131, (1991).
Pontzel, Biosis AB #91:526987, (1991).
Sierra et al., "Multiple Sclerosis", Secretion of IL-2, IFN-.tau.+PGE.sub.2 +Effect, Neurologia (1992), 7/9 pp. 247-253.
Arnason, B.G.W., and Reder, A.T., "Interferons and Multiple Sclerosis," Clin. Neuropharmacol. 17(6):495-547 (1994).
Brod, S.A., and Burns, D.K., "Suppression of Relapsing Experimental Autoimmune Encephalomyelitis in the SJL/J Mouse by Oral Administration of Type I Interferons," Neurology 44:1144-1148 (1994).
Bazer, F.W., and Johnson, H.M., "Type I Conceptus Interferons: Maternal Recognition of Pregnancy Signals and Potential Therapeutic Agents," Am. J. Reproduc. Immunol. 26:19-22 (1991).
Brod, S.A., et al., "Modification of Acute Experimental Autoimmune Encephalomyelitis in the Lewis Rat by Oral Administration of Type 1 Interferons," J. Interfer. & Cytokine Res. 15:115-122 (1995). Beta-1b is Effective in Relapsing-Remitting Multiple Sclerosis, I. Clinical Results of a Multicenter, Randomized, Double-Blind Placebo-Controlled Trial," Neurology 43:655-661 (1993).
Pontzer, C.H., et al., "Antiproliferative Activity of a Pregnancy Recognition Hormone, Ovine Trophoblast Protein-1," Cancer Res. 51:5304-5307 (1991).
Soos, J.M., et al., "The Novel Type I Interferon Tau Development and Superantigen Reactivation of Experimental Allergic Encephalomyelitis in Mice without Associated Toxicity," Faseb J. of Exper. Biol. 9(4):A1025 (1995).
Soos, J.M., and Johnson, H.M., "Type I Interferon Inhibition of Superantigen Stimulation: Implications for Treatment of Superantigen-Associated Disease," J. Interferon and Cytokine Res. 15:39-45 (1995).
Johnson Howard Marcellus
Schiffenbauer Joel
Soos Jeanne M.
Dehlinger Peter J.
Delaney Patrick R.
Petithory Joanne R.
Sholtz Charles K.
Tsang Cecilia J.
LandOfFree
Method for treatment of autoimmune diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treatment of autoimmune diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment of autoimmune diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-400303